BioSpace News Archive

Heska announced today an agreement to supply over 100 PetVetCare veterinary hospitals with in-house laboratory diagnostic equipment and supplies through 2024, which may be extended by the Parties.

TraceLink today announced that Normon Laboratories, has selected TraceLink’s serialization solutions to comply with the EU Falsified Medicines Directive (FMD) serialization requirements.

The Company will host a conference call that day at 5:30 PM ET to discuss the results and provide a general business update.

The call and webcast will follow the release of the third quarter financial results after market close.

Pursuant to the Supply Agreement, Innovasource will supply its custom-formulated, EPA-registered hydrogen peroxide based disinfectant product to Medizone for use in the AsepticSure Disinfection System.

Natera has entered into a research collaboration with Imperial College London and the University of Leicester, U.K., to leverage the company’s Signatera personalized ctDNA technology to evaluate retrospectively the use of ctDNA to detect disease recurrence in women breast cancer patients.

Aytu BioScience today announced that it presented six posters demonstrating the clinical potential of MiOXSYS, the company’s rapid in vitro diagnostic system for the qualitative measurement of static oxidation-reduction potential (sORP) in human semen, to be used as an aid in the diagnosis of infertility in males.

The MyoSure MANUAL device joins the MyoSure suite of gynecologic surgical products.

Varian Medical Systems announced a 71-year-old male with prostate cancer became the first patient in Australia to be treated on the Halcyon system at ROC in Toowoomba by Brisbane-based Icon Group.

Baxter announced a new PD-first program for its employees and family members aimed at improving education and awareness of dialysis treatment options, including peritoneal dialysis (PD).